Bioequivalence studies are fundamental in ensuring that generic drugs are as effective and safe as their brand-name counterparts. These studies compare the rate and extent of drug absorption in the body to demonstrate that a generic formulation behaves similarly to the reference product. But what defines a “passing” bioequivalence study? Let’s break it down: Bioequivalence…
When applying the BCS based biowaiver approach, comparative in vitro dissolution tests should be conducted using one batch representative of the proposed commercial manufacturing process for the test product relative to the reference product. The test product should originate from a batch of at least 1/10 of production scale or 100,000 units, whichever…
The Abbreviated New Drug Application (ANDA) is a crucial regulatory pathway in the United States for the approval of generic drugs. This post provides a detailed overview of the ANDA process, its requirements, and significance in the pharmaceutical industry. 1. Purpose of ANDA ANDA allows pharmaceutical companies to demonstrate that their generic drug product…
